GNMT and metabolic dysfunction-associated steatotic liver disease: Our recent paper reported that two pathways such as fatty acid β-oxidation (112) and stearate biosynthesis are upregulated and shared by human NASH, NAFLD mouse models with glycine N-methyltransferase deficiency (GNMT-KO), and high-fat-cholesterol diet (HFCD) models (77).